Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Short-term Investments: 2009-2024

Historic Short-term Investments for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $1.6 billion.

  • UNITED THERAPEUTICS's Short-term Investments fell 19.47% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 19.47%. This contributed to the annual value of $1.6 billion for FY2024, which is 12.12% down from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Short-term Investments of $1.6 billion as of FY2024, which was down 12.12% from $1.8 billion recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Short-term Investments registered a high of $1.9 billion during FY2022, and its lowest value of $1.0 billion during FY2021.
  • Moreover, its 3-year median value for Short-term Investments was $1.8 billion (2023), whereas its average is $1.7 billion.
  • In the last 5 years, UNITED THERAPEUTICS's Short-term Investments soared by 81.24% in 2022 and then decreased by 12.12% in 2024.
  • Yearly analysis of 5 years shows UNITED THERAPEUTICS's Short-term Investments stood at $1.1 billion in 2020, then fell by 5.51% to $1.0 billion in 2021, then skyrocketed by 81.24% to $1.9 billion in 2022, then dropped by 4.85% to $1.8 billion in 2023, then fell by 12.12% to $1.6 billion in 2024.